Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Potential Therapeutic Strategies for Steatosis, Oxidative Stress, Inflammation, and Fibrosis in Liver Disease
- Muriel P. , et al.
2. β-Alanine alleviated non-alcoholic fatty liver disease via regulation of hepatic sulfur-amino acid metabolism in mice
- Lee J. , et al.
3. High-fat diet, gut dysbiosis, and oxidative stress: A synergistic triangle in metabolic dysfunction-associated steatotic liver disease pathogenesis
- Zhang Z.R. , et al.
4. N-acetylcysteine reduces the hepatic complications of social isolation stress through modulation of interleukin 1 and 6 gene expression and liver enzymes in mice
- Asgharzadeh J. , et al.
5. Effect of high-dose N-acetyl cysteine on the clinical outcome of patients with diabetic peripheral neuropathy: a randomized controlled study
- Emara S.M. , et al.
6. Optimized Protocol for Primary Rat Hepatocyte Isolation and a Model for Investigating Experimental Steatosis
- Harb A.A. , et al.
7. New Approach Combination-Dosed Therapy for Nonalcoholic Steatohepatitis Versus Vitamin E: A Randomized Controlled Trial
- Zakaria A.Y. , et al.
8. Senkyunolide A mitigates lipid deposition in hyperlipidemic hepatocytes through SIRT6-mediated suppression of oxidative stress and fetuin-A
- Ko J.H. , et al.
10. A Comparative Study of N-Acetyl Cysteine, Rosuvastatin, and Vitamin E in the Management of Patients with Non-Alcoholic Steatohepatitis: A Randomized Controlled Trial
- Zakaria A.Y. , et al.
11. Liver ischemia reperfusion injury: Mechanisms, cellular pathways, and therapeutic approaches
- de Oliveira T.H.C. , et al.
12. A new opportunity for N-acetylcysteine. An outline of its classic antioxidant effects and its pharmacological potential as an epigenetic modulator in liver diseases treatment
- Galicia-Moreno M. , et al.
13. Efficacy of N-Acetylcysteine on Liver Function and Metabolic Profiles in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Double-Blind, Randomized Controlled Trial
- Sinaeinejad M. , et al.
14. Vitamin E for people with non-alcoholic fatty liver disease
- Wen H. , et al.
15. Nutraceutical and dietary measures with potential for preventing/controlling non-alcoholic fatty liver disease and its complications
- Lewis Lujan L.M. , et al.
16. Polydopamine nanoparticles as a non-pharmaceutical tool in the treatment of fatty liver disease
- Carmignani A. , et al.
17. A Multidrug Donor Preconditioning Improves Steatotic Rat Liver Allograft Function and Recipient Survival After Transplantation
- Xu M. , et al.
18. N-Acetylcysteine and Its Immunomodulatory Properties in Humans and Domesticated Animals
- Tieu S. , et al.
19. Lipophagy: A potential therapeutic target for nonalcoholic and alcoholic fatty liver disease
- Han Y.H. , et al.
20. N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebo-controlled trial
- Morley K.C. , et al.
21. Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key
- Alonso-Peña M. , et al.
22. The efficacy of N-acetylcysteine in improving liver function: A systematic review and meta-analysis of controlled clinical trials
- Nikbaf-Shandiz M. , et al.